May 9 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.06 12.32 12.55
(-2.1 pct) (+2.4 pct) (+4.0 pct)
Operating 589 mln loss 187 mln 500 mln
(-15.2 pct)
Recurring 608 mln loss 191 mln 490 mln
(-19.5 pct)
Net
Net 576 mln loss 2.12 480 mln
(-16.7 pct)
EPS 152.47 yen loss 560.26 yen 126.93 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T